|
MPPE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.34559030584569E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.06760197641165E-11 |
| Normal-vs-Stage2 |
2.773200E-04 |
| Normal-vs-Stage3 |
8.56870130405696E-13 |
| Normal-vs-Stage4 |
1.62547753035369E-12 |
| Stage1-vs-Stage2 |
2.248000E-01 |
| Stage1-vs-Stage3 |
3.617700E-02 |
| Stage1-vs-Stage4 |
2.194900E-04 |
| Stage2-vs-Stage3 |
1.160040E-02 |
| Stage2-vs-Stage4 |
7.980300E-04 |
| Stage3-vs-Stage4 |
1.550240E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.23234755733392E-14 |
| Normal-vs-AfricanAmerican |
4.363100E-04 |
| Normal-vs-Asian |
6.09210015767303E-10 |
| Caucasian-vs-AfricanAmerican |
1.061200E-01 |
| Caucasian-vs-Asian |
2.719200E-01 |
| AfricanAmerican-vs-Asian |
3.551400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.12010001274143E-09 |
| Normal-vs-Female |
2.70761191245583E-12 |
| Male-vs-Female |
4.849800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.31159569053352E-11 |
| Normal-vs-Age(41-60Yrs) |
1.06690212220428E-11 |
| Normal-vs-Age(61-80Yrs) |
1.40120004488153E-09 |
| Normal-vs-Age(81-100Yrs) |
4.613800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.447600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.894000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.053200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.829000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.805400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.507400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.13210000041164E-07 |
| Classical-VS-Follicular |
4.92980000044163E-07 |
| Classical-VS-Other |
9.552800E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.82343029564436E-12 |
| Tall-VS-Other |
2.238600E-03 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.172650E-04 |
| Follicular-VS-Normal |
5.782400E-02 |
| Other-VS-Normal |
7.182799999228E-08 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.35249997260212E-09 |
| Normal-vs-N1 |
2.22044604925031E-16 |
| N0-vs-N1 |
1.57228999999592E-05 |
|
|
